HAE Stock Summary and Trading Ideas (Haemonetics | NYSE:HAE)

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

What symbol and exchange does Haemonetics shares trade?

Haemonetics trades on the NYSE stock market under the symbol HAE.

What is Haemonetics stock price doing today?

As of September 11, 2026, HAE stock price climbed to $102.69 with 426,960 million shares trading.

What is Haemonetics's Beta?

HAE has a beta of -0.00, meaning it tends to be less sensitive to market movements. HAE has a correlation of 0.00 to the broad based SPY ETF.

How much is Haemonetics worth?

HAE has a market cap of $4.67 billion. This is considered a Mid Cap stock.

How much money does Haemonetics make?

Last quarter Haemonetics reported $339 million in Revenue and $1.14 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.05.

What is the highest and lowest price Haemonetics traded in the last 3 year period?

In the last 3 years, HAE traded as high as $109.57 and as low as $47.32.

What are the top ETFs holding Haemonetics?

The top ETF exchange traded funds that HAE belongs to (by Net Assets): VTI, VB, VXF, MDY, VBR.

Is Haemonetics (HAE) a good investment?

HAE has outperformed the market in the last year with a return of +92.0%, while the SPY ETF gained +17.4%. In the last 3 month period, HAE beat the market returning +28.6%, while SPY returned +3.9%. However, in the most recent 2 weeks HAE has underperformed the stock market by returning -1.2%, while SPY returned -0.7%.

What are the support and resistance levels for Haemonetics (HAE)?

HAE support price is $99.09 and resistance is $103.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HAE shares will trade within this expected range on the day.